- GlobeNewswire•3 hours agoANTH INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Anthera Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of April 17, 2017
NEW YORK, Feb. 21, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased ...
- PR Newswire•3 days agoJohnson & Weaver, LLP Announces Investigations of Clovis Oncology, Inc., USANA Health Sciences, Inc., Anthera Pharmaceuticals, Inc., and PixarBio Corporation
Johnson & Weaver, LLP is investigating potential violations of federal and state securities laws by Clovis Oncology, Inc. (CLVS) and certain of its officers. On November 19, 2015, a class action lawsuit was filed against Clovis over alleged securities laws violations.
- Business Wire•4 days agoRobbins Arroyo LLP: Anthera Pharmaceuticals, Inc. (ANTH) Misled Shareholders According to a Recently Filed Class Action
Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Anthera Pharmaceuticals, Inc. in the U.S. District Court for the Northern District of California.
ANTH : Summary for Anthera Pharmaceuticals, Inc. - Yahoo Finance
Anthera Pharmaceuticals, Inc. (ANTH)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.65 x 100|
|Ask||0.65 x 500|
|Day's Range||0.62 - 0.68|
|52 Week Range||0.51 - 4.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.45|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|